Walleye Capital’s Oncorus, Inc. ONCR Stock Holding History

Walleye Capital’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,987	Closed	-$79K	–	2741
2021 Q4	$79K	Buy	+14,987	New	+$116K	﹤0.01%	1730
2021 Q2	–	Sell	-22,870	Closed	-$318K	–	1572
2021 Q1	$318K	Buy	+22,870	New	+$473K	0.02%	733

Other funds holding ONCR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Walleye Capital's ONCR Position: Q1 2022 in Review

Walleye Capital sold out of Oncorus, Inc. (ONCR) in Q1 2022, closing a stake of 14,987 shares — an estimated $79K sold.

Walleye Capital first reported a position in ONCR in Q1 2021 and held it in 2 quarters. The position peaked at $318K in Q1 2021. 56 funds tracked by Wall St. Rank hold ONCR as of Q1 2022.

Walleye Capital reported no remaining Oncorus, Inc. position as of Q1 2022 after selling out during the quarter.
Walleye Capital sold 14,987 Oncorus, Inc. shares in Q1 2022, an estimated $79K.
Walleye Capital first reported a position in Oncorus, Inc. in Q1 2021 and held it in 2 quarters.
Walleye Capital's Oncorus, Inc. position peaked at $318K in Q1 2021.
56 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q1 2022.

Based on Walleye Capital's 13F filing for Q1 2022, filed 16 May 2022.